News Archive

Truvian Sciences Raises More Than $105M in Series C Financing

FinSMEs- February 24, 2021

The company intends to use the funds to advance development of its automated benchtop blood testing system, paving the way to submit the device for U.S. Food and Drug Administration (FDA) clearance, and to scale its team in preparation for...... Read more

...

Truvian Closes $105M Series C Financing Round

360Dx- February 24, 2021

Truvian announced on Wednesday that it has closed a $105 million Series C financing round, bringing the total amount the company has raised to date to more than $150 million.... Read more

...

San Diego’s Truvian Sciences Raises $105M to Bring Common Wellness Blood Tests Closer to Home

San Diego Union Tribune- February 24, 2021

Truvian Sciences, a San Diego startup that’s developing a benchtop blood testing machine to bring rapid, point-of-care health screening to local pharmacies, medical clinics and corporate wellness centers, has raised $105 million in a third round of venture capital funding... Read more

...

Truvian Sciences Snares $105M for its Many-in-One Blood Testing Machine

FierceBiotech- February 24, 2021

With its eyes set on securing an FDA clearance for its automated bench top blood testing system, Truvian Sciences has raised more than $105 million in new financing for the final steps of its development. The series C round will...... Read more

...

Truvian Closes $105M Oversubscribed Series C

Mass Device- February 24, 2021

The benchtop system is designed to combine chemistries, immunoassays and hematology assays in one device, with the combination of such testing modalities allowing clinics to perform all standard blood tests during a routine check-up on-site, saving cost and time... Read more

...